Zoetis Inc. (ZTS)

Healthcare · Drug Manufacturers - Specialty & Generic · Data as of 2026-09-01

Bottom line

ZTS is trading at a discount to its history, near its historical support zone, and recent volume suggests money flowing in. Historically, this combination has been a favourable starting point for further research. Past patterns are not a guarantee of future results.

Valuation — Trading at a discount to its history (Green)

ZTS trades at 13× earnings, below its own 5-year average of 36× and below similar healthcare companies we track (29×, 52 peers). Historically this has been on the cheaper side for the stock. It also generates strong cash: a free-cash-flow yield of about 7%. Its current multiple sits around the 2nd percentile of its own last five years — toward the low end of its own range.

Price zones — Near its historical support zone (Green)

At $77.25, the stock is close to the lower end of its recent range. Over the past year ZTS has traded between $71.00 and $155.38; its historical support zone sits near $75.67 and resistance near $103.70. It is above one of its moving averages and below the other — a mixed trend picture.

52-week range $71.00–$155.38 · 50-day average $75.67 · 200-day average $103.70

Money flow — Money is flowing in (Green)

Recent trading in ZTS shows more volume on rising days than falling days, a pattern often described as accumulation. Volume on up days has been about 1.3× volume on down days over the last 30 sessions.

About the company

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses.

一句话结论

ZTS 相对自身历史处于折价水平,接近其历史支撑区,近期成交量显示资金正在流入。从历史来看,这样的组合是一个值得进一步研究的有利起点。过去的形态并不能保证未来的结果。

估值 — 相对自身历史处于折价水平

ZTS 目前的市盈率为 13×,低于其自身 5 年平均的 36×,并且低于我们追踪的同类Healthcare公司(29×,52 家)。从历史来看,这属于该股较便宜的一侧。它同时产生充沛的现金:自由现金流收益率约为 7%。它当前的估值倍数大约位于自身过去五年分布的第 2 百分位——处于自身区间的偏低位置。

价格区间 — 接近其历史支撑区

目前价格为 $77.25,接近其近期区间的下沿。过去一年 ZTS 的价格在 $71.00 到 $155.38 之间波动;其历史支撑区在 $75.67 附近,阻力区在 $103.70 附近。它位于其中一条均线上方、另一条下方——趋势信号并不一致。

资金流向 — 资金正在流入

ZTS 近期上涨日的成交量高于下跌日,这种形态常被称为吸筹。过去 30 个交易日,上涨日的成交量约为下跌日的 1.3×。

UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据,不构成任何投资建议。

UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.

Disclaimer · Risk